Author

Kelli L. Kuhen

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:non-human primate· 1

Frequent Co-Authors

Anders M. Eliasen· 1 shared Andrew Slade· 1 shared Anil K. GuptaiD· 1 shared Arnab K. ChatterjeeiD· 1 shared Ashley K. Woods· 1 shared Case W. McNamaraiD· 1 shared Elizabeth Vadas· 1 shared Fei Zhou· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

Anders M. Eliasen

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

A Prodrug Strategy to Reposition Atovaquone as a Long-Acting Injectable for Malaria Chemoprotection

Anil K. Gupta, Anders M. Eliasen, Wil Andahazy, Fei Zhou, Kerstin Henson, Victor Chi, Ashley K. Woods, Sean B. Joseph, Kelli L. Kuhen, John Wisler, Hanu Ramachandruni, James Duffy, Jeremy N. Burrows, Elizabeth Vadas, Andrew Slade, , Arnab K. Chatterjee

This paper develops three prodrug formulations of atovaquone for long-acting injectable malaria chemoprotection, showing two maintain therapeutic plasma levels for over 70 and 30 days in monkeys.

bioRxiv · Feb 8, 2024 · PreprintPharmacology & Toxicology